Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPANOVA versus olive oil in severe hypertriglyceridemia
NL-OMON40969Phase 3Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia (2 arms), sponsored by AstraZeneca. Started Sep 2014; status: active, not recruiting.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NL-OMON40969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40969.